Publication | Open Access
A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia
14
Citations
8
References
2022
Year
AcrySof IQ Vivity intraocular lens is a highly cost-effective treatment strategy with improved vision-related quality of life outcomes for presbyopic cataract surgery patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1